Parabilis Medicines, Inc. Common Stock (PBLS) — Financial Flexibility Index
Parabilis Medicines, Inc. Common Stock (PBLS) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-48.83 Million (operating CF $-49.20 Million minus capex $369.00K) represents 0% of total liabilities ($139.95 Million). Check Parabilis Medicines, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Parabilis Medicines, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Parabilis Medicines, Inc. Common Stock across 2 annual periods. See Parabilis Medicines, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Parabilis Medicines, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Parabilis Medicines, Inc. Common Stock. For the full company profile including market capitalisation, see PBLS market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.27x | $-123.41 Million | $-123.71 Million | $97.34 Million | ▼ -14.5% |
| 2024 | -1.11x | $-102.73 Million | $-103.61 Million | $92.81 Million | — |